Vincent Ossipow, PhD

Biochemistry University of Geneva, Geneva, Switzerland 
Molecular biology, NECL, neuroscience
Mean distance: 16.72 (cluster 11)
Cross-listing: Chemistry Tree


Sign in to add mentor
Marc Ballivet research scientist University of Geneva (Sineoculis) Delete Edit
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ossipow V. (2014) Editorial | Édito Biofutur. 3
Ossipow V. (2014) From immunotherapy to immuno-oncology | De l'immunothérapie à l'immuno-oncologie Biofutur. 26-29
Ossipow V, Fischer N. (2014) Preface Methods in Molecular Biology. 1131: v-vi
Mach B, Ossipow V. (2009) Monoclonal antibodies: From gene to medicine | Les anticorps monoc-lonaux: Du gène au médicament Biofutur. 26-30
Ossipow V. (2009) Editorial: An immunotherapeutic revolution | Éditorial: Une révolution immunothérapeutique Biofutur. 1
Ossipow V, Mach B. (2009) New formats and new technologies of monoclonal antibodies | Nouveaux formats et nouvelles technologies d'anticorps monoclonaux Biofutur. 31-34
Ossipow V. (2009) The monoclonal antibodies, growth engine of the pharmaceutical industry | Les anticorps monoclonaux. moteur de lo croissonce de l'industrie pharmaceumque Biofutur. 62-63
Pellissier F, Gerber A, Bauer C, et al. (2007) The adhesion molecule Necl-3/SynCAM-2 localizes to myelinated axons, binds to oligodendrocytes and promotes cell adhesion Bmc Neuroscience. 8
Ossipow V, Pellissier F. (2007) Neuroinflammation: Promises of glial cells. Glial cells: The awakening of the silent majority | Cellules gliales: L'éveil de la majorité silencieuse Biofutur. 24-28
Ossipow V. (2007) The glia, that great forgotten | La glie, cette grande oubliée Biofutur. 1
See more...